21 October 2026
: Case report
[In Press] Cryptococcal Meningitis in an Apparently Immunocompetent Patient With a Ventriculoatrial Shunt: Diagnostic Challenges of Negative Serum Cryptococcal Antigen
Challenging differential diagnosis, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Mustafa Nuaimi1ABDE, Sara Ubosy1BDEF, Habib Behjatnia1CEF, Patricia Couto2CDE, Antonio Crespo2ACE, Mario Madruga1ADE, Steve J. CarlanDOI: 10.12659/AJCR.954036
Am J Case Rep In Press; DOI: 10.12659/AJCR.954036
Available online: 2026-10-21, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Cryptococcal meningitis usually occurs in people with impaired cellular immunity, but it can also affect patients without a recognized immunodeficiency. Cerebrospinal fluid (CSF) shunts complicate recognition because symptoms may be subtle and serum studies may be unrevealing. We describe a case of a patient with a longstanding ventriculoatrial (VA) shunt whose CSF findings established the diagnosis despite a negative serum cryptococcal antigen result.
CASE REPORT
A 60-year-old man with a remote ventriculoperitoneal shunt subsequently converted to a VA shunt developed persistent headache and an episode of seizure-like activity 3 days after robotic cholecystectomy. He had no focal neurological deficit, and electroencephalography showed no epileptiform activity. Brain magnetic resonance imaging showed no mass lesion or hydrocephalus. Lumbar puncture revealed lymphocytic pleocytosis (101 cells/μL), CSF protein of 61 mg/dL, and glucose of 44 mg/dL. Serum cryptococcal antigen was negative, whereas CSF cryptococcal antigen was positive at a titer of 1: 40 and CSF culture grew Cryptococcus neoformans. The discordant serum result has an uncertain mechanism because assay-platform details and repeat or dilution testing were unavailable. He received liposomal amphotericin B and flucytosine, underwent VA shunt removal and external ventricular drainage, and later had shunt revision. Following clinical and microbiologic improvement, he received fluconazole consolidation and maintenance therapy and remained clinically well at 4-week follow-up.
CONCLUSIONS
A negative serum cryptococcal antigen result did not exclude meningitis in this patient with a CSF shunt. Persistent unexplained neurological symptoms warrant CSF evaluation when cryptococcosis remains clinically plausible. This case also illustrates the importance of antifungal therapy and coordinated neurosurgical management for suspected shunt-associated infection.
Keywords: Cerebral Cortex; Cryptococcus; Meningitis
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953701
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953543
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954216
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954932
Most Viewed Current Articles
07 Dec 2021 : Case report
28,712,695
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
180,721
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
124,419
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
08 May 2026 : Case report
95,462
DOI :10.12659/AJCR.952158
Am J Case Rep 2026; 27:e952158






